In the remaining 5–10% of patients with clinically typical CHARGE syndrome, the apparent lack of CHD7 mutations may be explained by alterations in CHD7 that are not detected with routine genotyping strategies. The gene discussed is CHD7; the disease is CHARGE syndrome.